Physician profile
Neil Joshi
NPI 1598227605
$1,376.04
in general payments reported to CMS, 2019-2025
9 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $260 · 2021: $411 · 2022: $163 · 2023: $243 · 2024: $58.44 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $500.69 | 2021-2025 | Universal Neuro 3, Adherus Autospray Dural Sealant, Core |
| Penumbra, INC. | $285.44 | 2020-2021 | |
| Depuy Synthes Sales INC. | $228.97 | 2020-2025 | Trialtis, Teligen, Symphony |
| Orthofix Medical, INC. | $135.93 | 2022 | |
| Boston Scientific Corporation | $71.54 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $65.83 | 2021-2025 | Inceptiv, Mazor X System |
| Abbott Laboratories | $34.21 | 2025 | Infinity |
| Axogen | $26.88 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Globus Medical, INC. | $26.55 | 2025 | Omnia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.